280 related articles for article (PubMed ID: 9343506)
1. Increase in primary liver cancer in the UK, 1979-94.
Taylor-Robinson SD; Foster GR; Arora S; Hargreaves S; Thomas HC
Lancet; 1997 Oct; 350(9085):1142-3. PubMed ID: 9343506
[No Abstract] [Full Text] [Related]
2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology of primary and secondary liver cancers].
Jepsen P; Kissmeyer-Nielsen P
Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of cancer of the liver and intrahepatic bile ducts in an Australian population.
Luke C; Price T; Roder D
Asian Pac J Cancer Prev; 2010; 11(6):1479-85. PubMed ID: 21338184
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
[TBL] [Abstract][Full Text] [Related]
6. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver.
Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H
Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601
[TBL] [Abstract][Full Text] [Related]
7. Rising incidence of primary liver cancer in Brunei Darussalam.
Chong RJ; Abdullah MS; Hossain MM; Telisinghe PU; Chong VH
Asian Pac J Cancer Prev; 2013; 14(6):3473-7. PubMed ID: 23886131
[TBL] [Abstract][Full Text] [Related]
8. Markedly Increased Rate of Primary Liver Malignancies at Autopsy in Male US Veterans.
Nasir A; Manivel JC; Yousaf H; Albrecht JH; Dykoski R; Mesa H
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):316-318. PubMed ID: 27574757
[No Abstract] [Full Text] [Related]
9. Liver cancer among employees in Denmark.
Døssing M; Petersen KT; Vyberg M; Olsen JH
Am J Ind Med; 1997 Sep; 32(3):248-54. PubMed ID: 9219654
[TBL] [Abstract][Full Text] [Related]
10. Time and deprivation trends in incidence of primary liver cancer subtypes in England.
Konfortion J; Coupland VH; Kocher HM; Allum W; Grocock MJ; Jack RH
J Eval Clin Pract; 2014 Aug; 20(4):498-504. PubMed ID: 24902884
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of cholangiocarcinoma.
Shaib Y; El-Serag HB
Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
[TBL] [Abstract][Full Text] [Related]
12. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of liver cancer: an overview.
Srivatanakul P; Sriplung H; Deerasamee S
Asian Pac J Cancer Prev; 2004; 5(2):118-25. PubMed ID: 15244512
[TBL] [Abstract][Full Text] [Related]
14. Association of nonalcoholic fatty liver disease and liver cancer.
Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary malignancy.
Jones BA; Gores GJ
Clin Liver Dis; 1998 May; 2(2):437-49, xi-xii. PubMed ID: 15560042
[TBL] [Abstract][Full Text] [Related]
16. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families.
Strautnieks SS; Byrne JA; Pawlikowska L; Cebecauerová D; Rayner A; Dutton L; Meier Y; Antoniou A; Stieger B; Arnell H; Ozçay F; Al-Hussaini HF; Bassas AF; Verkade HJ; Fischler B; Németh A; Kotalová R; Shneider BL; Cielecka-Kuszyk J; McClean P; Whitington PF; Sokal E; Jirsa M; Wali SH; Jankowska I; Pawłowska J; Mieli-Vergani G; Knisely AS; Bull LN; Thompson RJ
Gastroenterology; 2008 Apr; 134(4):1203-14. PubMed ID: 18395098
[TBL] [Abstract][Full Text] [Related]
17. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
[TBL] [Abstract][Full Text] [Related]
18. Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.
Hemminki K; Sundquist K; Sundquist J; Försti A; Liska V; Hemminki A; Li X
Int J Cancer; 2023 Mar; 152(6):1107-1114. PubMed ID: 36196489
[TBL] [Abstract][Full Text] [Related]
19. Descriptive epidemiology of bile duct carcinoma in Osaka.
Ikeda A; Miyashiro I; Nakayama T; Ioka A; Tabuchi T; Ito Y; Tsukuma H
Jpn J Clin Oncol; 2013 Nov; 43(11):1150-5. PubMed ID: 24014885
[TBL] [Abstract][Full Text] [Related]
20. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
El-Serag HB; Engels EA; Landgren O; Chiao E; Henderson L; Amaratunge HC; Giordano TP
Hepatology; 2009 Jan; 49(1):116-23. PubMed ID: 19085911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
